Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rationale for IL-1 β targeted therapy to improve harvested organ viability, allograft tolerance, replant success and for conditions characterized by reduced or absent arterial perfusion

Rationale for IL-1 β targeted therapy to improve harvested organ viability, allograft tolerance, replant success and for conditions characterized by reduced or absent arterial perfusion

US Patent 8389474 · Granted Mar 5, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rifle rest for a vertical support post and associated methods2024
Rifle rest for a monopole2023
Eyeglasses accessory for eyeglasses retention including medially angled retainer2023
Eyeglasses accessory for eyeglasses retention and associated methods2022
Eyeglasses accessory for combined hearing aid and/or eyeglasses retention2022
Adjustable in-situ device to stabilize and maintain positioning of eyewear on a 2015
Devices to dilate nasal airways for various applications involving: activities u2015
Apparatus for indicating proper orientation for oral and nasal inhalers1999
Blood collection tube holder1993
Needle guard for blood collection1993
Blood collection tube holder1992
Holder for double ended blood collection retractable needle1991